A year after the first samRNA vaccine approval, experts say similar vaccines in development are likely to face scientific and ...

In one of our recent articles about 10 High Growth Non-Tech Stocks That Are Profitable in 2024, we talked about how the US ...

Colossal, the company founded to try to restore the mammoth to the Arctic tundra, has also decided to tackle a number of ...

Based in Cambridge, Massachusetts, Moderna, Inc. (MRNA) is a leading biotechnology company that develops messenger RNA (mRNA) ...

European Patent Office to grant a patent for DRP® companion diagnostic for Allarity’s stenoparib cancer therapyPatent applications for the ...

Early data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such ...

A research team from the University of Barcelona's Institute of Neurosciences described a novel molecular mechanism that ...

Altered RNA processing is highly damaging to neurons, adding a new toxic component to the evolution of AD. Currently, the ...

Two public companies focused on RNA editing therapies, Korro Bio and ProQR, enjoyed impressive stock surges powered by their best-ever one day gains; their share prices lifted by Wave Life Sciences ...

Review explores how microRNAs (miRNAs) interact in cancer development, their potential in diagnosis, and innovative ...

Cell membranes from comb jellies reveal a new kind of adaptation to the deep sea: curvy lipids that conform to an ideal shape ...